Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells

Molecular and Cellular Biology

Volumn 17, Issue 7, 1997, Pages 4169-4177

  Thompson, Leslie M ^a   Raffioni, Simona ^a   Wasmuth, John J ^a   Bradshaw, Ralph A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PHOSPHOLIPASE C; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RECEPTOR SUBTYPE;

ACHONDROPLASIA; ARTICLE; AUTOPHOSPHORYLATION; BONE GROWTH; CELL DIFFERENTIATION; CELL STRAIN; CONTROLLED STUDY; DWARFISM; EMBRYO; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR GENE; SIGNAL TRANSDUCTION;

EID: 0030950406     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.7.4169     Document Type: Article

References (50)

1. Adam, M. A., N. Ramesh, D. A. Miller, and W. R. A. Osborne. 1991. Internal initiation of translation in retroviral vectors carrying picornavirus 5′ non-translated regions. J. Virol. 65:4985-4990.
2. Bellus, G. A., I. McIntosh, E. A. Smith, A. S. Aylsworth, I. Kaitila, W. A. Horton, G. A. Greenhaw, J. T. Hecht, and C. A. Francomano. 1995. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat. Genet. 10:357-359.
3. Bellus, G. A., K. Gaiidenz, E. H. Zackai, L. A. Clarke, J. Szabo, C. A. Francomano, and M, Muenke. 1996. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat. Genet. 14:174-176.
4. Bonaventure, J., F. Rousseau, L. Legeai-Mallet, A. Munnich, and P. Maroteaux. 1996. Common mutations in the fibroblast growth factor receptor 3 (FGFR3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Am. J. Med. Genet. 63:145-148.
5. Burgess, W. H., and T. Maciag. 1989. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58:575-606.
6. Chellaiah, A. T., D. G. McEwen, S. Werner, J. Xu, and D. M. Ornitz. 1994. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/ FGF-1. J. Biol. Chem. 269:11620-11627.
7. Chen, C., and H. Okayama, 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
8. Claesson-Welsh, L., A. Hammacher, B. Westermark, C.-H. Heldin, and M. Nister. 1989. Identification and structural analysis of the A type receptor for platelet-derived growth factor. Similarities with the B type receptor. J. Biol. Chem. 264:1742-1747.
9. Colvin, J. S., B. A. Bohne, G. W. Harding, D. G. McEwen, and D. M. Ornitz. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12:390-397.
10. Deng, C., A. Wynshaw-Boris, F. Zhou, A. Kuo, and P. Leder. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921.
11. Foehr, E., R. Fujii, S. Raffioni. and R. A. Bradshaw. Unpublished data.
12. Green, P. J., F. S. Walsh, and P. Doherty. 1996. Promiscuity of fibroblast growth factor receptors. Bioessays 18:639-646.
13. Ikegawa, S., Y. Fukushima, M. Isomura, F. Takada, and Y. Nakamura. 1995. Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients. Hum. Genet. 96:309-311.
14. Jaye, M., J. Schlessinger, and C. A. Dionne. 1992. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim. Biophys. Acta 1135:185-199.
15. Johnson, D. E., and L. T. Williams. 1993. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60:1-41.
16. Jones, K. L. 1997, p. 346-351. Smith's recognizable patterns of human malformation. W. B. Saunders, Philadelphia, Pa.
17. Keegan, K., D. E. Johnson, L. T. Williams, and M. J. Hayman. 1991. Isolation of an additional member of the fibroblast growth factor receptor family. FGFR-3. Proc. Natl. Acad. Sci. USA 88:1095-1099.
18. Lin, H.-Y., J. Xu, D. M. Ornitz, S. Halegoua, and M. J. Hayman. 1996. The fibroblast growth factor receptor-1 is necessary for the induction of neurite outgrowth in PC12 cells by aFGF. J. Neurosci. 16:4579-4587.
19. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120-1124.
20. Meyers, G. A., S. J. Orlow, I. R. Munro, K. A. Przylepa, and E. W. Jabs. 1995. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat. Genet. 11:462-464.
21. Meyers, G. A., D. Day, R. Goldberg, D. L. Daentl, K. A. Przylepa, L. J. Abrams, J. M. Graham, Jr., M. Feingold, J. B. Moeschler, E. Rawnsley, A. F. Scott, and E. W. Jabs. 1996. FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am. J. Hum. Genet. 58:491-498.
22. Muenke, M., and U. Schell. 1995. Fibtoblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11:308-313.
23. Mulvihill, J. J. 1995. Craniofacial syndromes: no such thing as a single genetic disease. Nat. Genet. 9:101-103.
24. Naski, M. C., Q. Wang, J. Xu, and D. M. Ornitz. 1996. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13:233-237.
25. Obermeier, A., R. Lammers, K.-H. Wiesmuller, G. Jung, J. Schlessinger, and A. Ullrich. 1993. Identification of Trk binding sites for SHC and phosphatidylinositol 3′-kinase and formation of multimeric signaling complex. J. Biol. Chem. 268:22963-22966.
26. Obermeier, A., R. A. Bradshaw, K. Seedorf, A. Choidas, J. Schlessinger, and A. Ullrich. 1994. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLCγ. EMBO J. 13:1585-1590.
27. Peters, K., D. Ornitz, S. Werner, and L. Williams. 1994. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155:423-430.
28. Przylepa, K. A., W. Paznekas, M. Zhang, M. Golabi, W. Bias, M. J. Bamshad, J. C. Carey, B. D. Hall, R. Stevenson, S. J. Orlow, M. M. Cohen, Jr., and E. W. Jabs. 1996. Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nat. Genet. 13:492-494.
29. Raffioni, S., and R. A. Bradshaw. Unpublished data.
30. Rimoin, D. L., and R. S. Lachman. 1993. Genetic disorders of the osseous skeleton, p. 557-689. In P. Beighton (ed.), McKusick's heritable disorders of connective tissue. Mosby, St. Louis, Mo.
31. Ronnstrand, L., L. Terrecio, L. Claesson-Welsh, C.-H. Heldin, and K. Rubin. 1988. Characterization of two monoclonal antibodies reactive with the external domain of the platelet-derived growth factor receptor. J. Biol. Chem. 263:10429-10435.
32. Rousseau, F., J. Bonaventure, L. Legeai-Mallet, A. Pelet, J.-M. Rozet, P. Marateaux, M. Le Merrer, and A. Munnich. 1994. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371: 252-2547
33. Rousseau, F., V. El Chouzzi, A. L. Delezoide, L. Legeai-Mallet, M. Le Merrer, A. Munnich, and J. Bonaventure. 1996. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TDI). Hum. Mol. Genet. 5:509-512.
34. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
35. Schlessinger, J., and A. Ullrich. 1992. Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391.
36. Shiang, R., L. M. Thompson, Y.-Z. Zhu, D. M. Church, T. J. Fielder, M. Bocian. S. T. Winoker, and J. J. Wasmuth. 1994. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342.
37. Spivak-Kroizman, T., M. Mohammadi, P. Hu, M. Jaye, J. Schlessinger. and I. Lax. 1994. Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells. J. Biol. Chem. 269:14419-14423.
38. Sternberg, M. J., and W. J. Gullich. 1989. Neu receptor dimerization. Nature 339:587.
39. Superti-Furga, A., G. Eich, H. U. Bucher, J. Wisser, A. Giedon, R. Gitzelmann, and B. Steinmann. 1995. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur. J. Pediatr. 154:215-219.
40. Tavormina, P., R. Shiang, L. M. Thompson. Y.-Z. Zhu, D. J. Wilkin, R. S. Lachman, W. R. Wilcox, D. L. Rimoin, D. H. Cohn, and J. J. Wasmuth. 1995. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9:321-328.
41. Tavormina, P., D. L. Rimoin, D. H. Cohn, Y.-Z. Zhu, R. Shiang, and J. J. Wasmuth. 1995. Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I. Hum. Mol. Genet. 4:2175-2177.
42. Thompson, L. M., S. Plummer, M. Schalling, M. R. Attherr, J. F. Gusella, D. E. Housman, and J. J. Wasmuth. 1991. A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. Genomics 11:1133-1142.
43. Thompson, L. M., S. Raffioni, Y.-Z. Zhu, and R. A. Bradshaw. 1997. Unpublished data.
44. Tischler, A. S., and L. A. Greene. 1975. Nerve growth factor-induced process formation by cultured rat pheochromocytoma cells. Nature 258:341-342.
45. Webster, M. K., and D. J. Donoghue. 1996. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15:520-527.
46. Weiner, D. B., J. Liu, J. A. Cohen, W. V. Williams, and M. I. Greene. 1989. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature 339:230-231.
47. Williams, L. T. 1989. Signal transduction by platelet-derived growth factor receptor. Science 243:1564-1570.
48. Wu, Y. Y., and R. A. Bradshaw. 1993. Effect of nerve growth factor and fibroblast growth factor on PC1 2 cells: inhibition by orthovanadate. J. Cell Biol. 121:409-422.
49. Wu, Y. Y., and R. A. Bradshaw. 1996. Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat-3 signaling pathway in a variant PC12 cell (E2) line. J. Biol. Chem. 271:13023-13032.
50. Wu, Y. Y., and R. A. Bradshaw. 1996. Synergistic induction of neurite outgrowth by nerve growth factor or epidermal growth factor and interleukin-6 in PC12 cells. J. Biol. Chem. 271:13033-13039.